Sigachi Fire Slashes Capacity, Downgrades Rating; Rebuilds with ₹493 Cr Capex

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorIshaan Verma|Published at:
Sigachi Fire Slashes Capacity, Downgrades Rating; Rebuilds with ₹493 Cr Capex
Overview

Sigachi Industries faces significant challenges after a fire destroyed 30% of its capacity, leading to a net loss and credit rating downgrade. The company is shifting production, planning a ₹493 crore expansion, and opening a new R&D center to rebuild market share and focus on long-term growth in the API and excipient segments. FIIs recently increased their stake.

Fire Halts Sigachi Operations, Triggers Rating Downgrade

Sigachi Industries Limited is navigating a critical recovery phase following a devastating fire incident at its Hyderabad facility in June 2025. The blaze obliterated nearly 30% of the company's total installed production capacity, severely impacting operations and prompting a credit rating downgrade. This incident resulted in a significant net loss for the first half of fiscal year 2026.

Financial Strain and Credit Watch

The loss of capacity, with the affected unit previously contributing roughly 20% to consolidated revenue, led Sigachi Industries to report a net loss of ₹90.44 crore in H1FY26. This figure includes substantial provisions for compensation, plant damages, and inventory write-offs. Consequently, CARE Ratings Limited revised the company's credit rating from CARE A- to CARE BBB+, placing it on "Rating Watch with Negative Implications" due to liquidity pressures and anticipated increased leverage.

Funding and Recovery Efforts

To bridge financial gaps while awaiting an estimated ₹51 crore in insurance claims, Sigachi is issuing ₹125 crore in Non-Convertible Debentures (NCDs). Management has swiftly rerouted production to its Dahej and Jhagadia units in Gujarat. Debottlenecking strategies are underway, aiming to boost total capacity to 18,000 MTPA by the fourth quarter of FY26.

Ambitious Expansion and R&D Push

Sigachi Industries has detailed a robust capital expenditure plan of ₹493 crore over the next two to three years. This includes a major 12,000 MTPA expansion at the Dahej SEZ and the development of a new Croscarmellose Sodium (CCS) facility. A new R&D Center in Hyderabad is slated for inauguration in July 2025, housing over 30 scientists to accelerate API development for regulated markets.

Leadership and Long-Term Vision

Reinforcing its strategic direction, Sigachi appointed Atul Dhavle as Chief People Officer, leveraging his three decades of experience to align talent strategy with growth goals. Despite the recent operational setback, the company highlights a 22% revenue growth in FY25 and its focus on high-value nutrition and API segments as indicators of enduring strength and commitment to long-term value creation.

Market Response

On Friday, shares of Sigachi Industries Ltd. declined 1.86% to ₹29.58, trading near their 52-week low. The company, with a market capitalization exceeding ₹1,100 crore, saw Foreign Institutional Investors increase their stake to 3.10% as of September 2025.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.